A phase I study of ZD 1839 (Iressa) [gefitinib] in combination with irinotecan, leucovorin [folinic acid], and 5-fluorouracil in previously untreated, stage IV colorectal cancer
Phase of Trial: Phase I
Latest Information Update: 08 Feb 2013
At a glance
- Drugs Gefitinib (Primary) ; Fluorouracil; Folinic acid; Irinotecan
- Indications Colorectal cancer
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 25 Oct 2007 Status changed from in progress to completed.
- 15 Sep 2005 New trial record.